We are live on ! Find out more
HURA

TuHURA Biosciences
HURA

13 hedge funds and large institutions have $51K invested in TuHURA Biosciences in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

44% more funds holding

Funds holding: 9 → 13 (+4)

26% more capital invested

Capital invested by funds: $40.4K → $51K (+$10.6K)

0.17% less ownership

Funds ownership: 0.2% → 0.04% (-0.17%)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
13
Holders Change
+4
Holders Change %
+44.44%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$15.9K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$11.6K
3
HF
HRT Financial
New York
+$9.37K
4
Jane Street
Jane Street
New York
+$7.96K
5
TRCT
Tower Research Capital (TRC)
New York
+$1.54K

Top Sellers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$14.6K
2
SWP
Stratos Wealth Partners
Ohio
-$3.39K
3
NCM
Nantahala Capital Management
Connecticut
-$1.06K
4
GPFA
Game Plan Financial Advisors
Ohio
-$7
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$14.4K +$15.9K +3,961 New
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$10.5K +$11.6K +2,880 New
HF
3
HRT Financial
New York
$8K +$9.37K +2,332 New
Jane Street
4
Jane Street
New York
$7.21K +$7.96K +1,982 New
Geode Capital Management
5
Geode Capital Management
Massachusetts
$4.49K – – –
TRCT
6
Tower Research Capital (TRC)
New York
$1.9K +$1.54K +384 +276%
Vanguard Group
7
Vanguard Group
Pennsylvania
$1.29K – – –
NCM
8
Nantahala Capital Management
Connecticut
$1.28K -$1.06K -264 -42%
State Street
9
State Street
Massachusetts
$1.11K – – –
Qube Research & Technologies (QRT)
10
Qube Research & Technologies (QRT)
United Kingdom
$686 +$759 +189 New
Osaic Holdings
11
Osaic Holdings
Arizona
$94 – – –
Wells Fargo
12
Wells Fargo
California
$3 +$4 +1 New
Acadian Asset Management
13
Acadian Asset Management
Massachusetts
– -$14.6K -3,641 -100%
SWP
14
Stratos Wealth Partners
Ohio
– -$3.39K -571 Closed
GPFA
15
Game Plan Financial Advisors
Ohio
– -$7 -1 Closed

HURA Hedge Fund Activity: Q1 2024 in Review

13 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q1 2024, worth a combined $51K — up 26% from $40.4K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new HURA positions and 2 closed out — a net gain of 4 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $15.9K. The largest seller was Acadian Asset Management, cutting an estimated $14.6K.

  • 13 institutional investors held TuHURA Biosciences (HURA) as of Q1 2024, up from 9 in Q4 2023.
  • Funds reported $51K of TuHURA Biosciences stock for Q1 2024, up 26% quarter-over-quarter.
  • 6 funds opened new TuHURA Biosciences positions in Q1 2024 and 2 closed out, a net change of +4 holders.
  • The largest TuHURA Biosciences buyer in Q1 2024 was UBS Group, an estimated $15.9K added.
  • The largest TuHURA Biosciences seller in Q1 2024 was Acadian Asset Management, an estimated $14.6K sold.

Based on aggregated 13F filings for Q1 2024.